Wade, They maintained their full year revenue guidance at 1.28-1.3 billion meaning what... 364 million compared with 335 million this quarter. Since the EPS was much lower last year, I don't think people are going to fret over revenue comparisons with the trial looming. They're probably low-balling it anyway.